4,2',4'-三羟基-6'-甲氧基查耳酮 TN1727
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 62014-87-3 | ¥5,900.00 | 询底价 |
1 mL | 62014-87-3 | ¥2,420.00 | 询底价 |
5 mg | 62014-87-3 | ¥2,570.00 | 询底价 |
50 mg | 62014-87-3 | ¥8,120.00 | 询底价 |
1 mg | 62014-87-3 | ¥1,190.00 | 询底价 |
10 mg | 62014-87-3 | ¥3,790.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Helichrysetin
描述: Helichrysetin 是从豆蔻果实中分离出的一种天然产物,是一种 DNA 结合抑制剂,可抑制原位导管癌DCIS 的形成。它抑制细胞生长,可诱导 A549 细胞凋亡。
体外活性: Searching for anti-HIV-1 protease (PR) inhibitors of Thai medicinal plants led to the isolation of a new cyclohexenyl chalcone named panduratin C (1) and chalcone derivatives (2-6) from the methanol extract of Boesenbergia pandurata rhizomes. The known compounds were identified to be panduratin A (2), hydroxypanduratin A (3), Helichrysetin (4), 2',4',6'-trihydroxyhydrochalcone (5), and uvangoletin (6). The structures of all compounds were elucidated on the basis of chemical and spectroscopic methods. It was found that 3 possessed the most potent anti-HIV-1 PR activity with an IC50 value of 5.6 microM, followed by 2 (IC50 = 18.7 microM), whereas other compounds exhibited only mild activity.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 22.5 mg/mL (78.59 mM)
关键字: Inhibitor | Apoptosis | growth | Helichrysetin | DCIS | inhibit | cell | cycle | ID2 | anticancer
相关产品: 3-Nitropropanoic acid | L-Theanine | Dihydrorotenone | Nirogacestat | Eriocitrin | (S)-(+)-Rolipram | Infigratinib | Rottlerin | Nimbolide | HBDDE
相关库: Anti-Tumor Natural Product Library | Selected Plant-Sourced Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Inhibitor Library | Anti-Cancer Active Compound Library | Flavonoid Natural Product Library | RO5 Drug-like Natural Product Library | Anti-Viral Compound Library | Bioactive Compound Library
4,2',4'-三羟基-6'-甲氧基查耳酮 TN1727信息由TargetMol中国为您提供,如您想了解更多关于4,2',4'-三羟基-6'-甲氧基查耳酮 TN1727报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途